2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 14.319 | 16.628 | 12.875 | 11.480 | 12.668 | 10.284 | 2.142 | 485 | 666 | 1.380 |
Total Income - EUR | 14.542 | 16.635 | 12.919 | 11.491 | 12.668 | 10.284 | 2.142 | 485 | 3.439 | 3.516 |
Total Expenses - EUR | 21.704 | 19.452 | 15.419 | 8.796 | 20.447 | 19.545 | 17.317 | 16.294 | 63.991 | 17.565 |
Gross Profit/Loss - EUR | -7.162 | -2.817 | -2.499 | 2.695 | -7.779 | -9.262 | -15.175 | -15.809 | -60.552 | -14.049 |
Net Profit/Loss - EUR | -7.591 | -3.316 | -2.885 | -10.079 | -8.159 | -9.570 | -15.240 | -15.823 | -60.569 | -14.049 |
Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Varlasmed Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 5.661 | 3.676 | 3.639 | 3.503 | 3.438 | 3.372 | 6.320 | 7.652 | 7.020 | 6.344 |
Current Assets | 116.185 | 112.179 | 104.741 | 90.283 | 76.612 | 63.298 | 31.806 | 9.061 | 4.439 | 4.302 |
Inventories | 4.239 | 0 | 0 | 0 | 0 | 0 | 444 | 3.053 | 3.508 | 3.497 |
Receivables | 100.974 | 108.547 | 104.662 | 89.061 | 76.525 | 63.202 | 31.345 | 5.779 | 914 | 735 |
Cash | 10.972 | 3.632 | 79 | 1.222 | 87 | 96 | 17 | 229 | 17 | 70 |
Shareholders Funds | 11.811 | 8.594 | 5.621 | -4.554 | -12.629 | -21.955 | -36.737 | -51.746 | -112.475 | -126.182 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 83 | 81 | 81 | 81 |
Debts | 110.035 | 107.261 | 102.759 | 98.339 | 92.680 | 88.625 | 78.177 | 71.699 | 127.184 | 140.069 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8622 - 8622" | |||||||||
CAEN Financial Year |
8622
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Varlasmed Srl